American Healthcare REIT Inc. (AHR)
NYSE NYSE Primary 
XDUS 
What's in the Offing for American Healthcare This Earnings Season?
While AHR's Q3 earnings are likely to have benefited from favorable SHOP operating trends and a well-diversified tenant base, high interest expenses raise concerns.
MOBs, Office But No Need For Life Support
Unlike in traditional office, healthcare requires in-office interactions, which reduces the risk of ‘work from home'. Outpatient services are taking market share from inpatient (hospital) settings due to better costs and, in some cases, outcomes. America's rapidly aging population is a tailwind for all healthcare real estate.
Is the Options Market Predicting a Spike in American Healthcare REIT, Inc. (AHR) Stock?
Investors need to pay close attention to American Healthcare REIT, Inc. (AHR) stock based on the movements in the options market lately.
The State Of REITs: October 2024 Edition
REITs achieved their 5th straight month in the black with a +3.09% average total return in September and +9.61% year to date. Mid-cap (+5.01%), large cap (+3.41%) and small cap REITs (+2.59%) averaged solid gains in September. Micro caps (-0.42%) again averaged a negative total return. 72.3% of REIT securities had a positive total return in September.
American Healthcare REIT: Capitalizing On Supply And Demand Imbalance In Healthcare Real Estate
American Healthcare REIT is a top choice due to its diverse portfolio, strong management, and strategic capital allocation, benefiting from demographic tailwinds and supply-demand imbalances. The REIT's business model focuses on long-term leases with experienced healthcare operators, ensuring reliable revenue and resilience across various property types. Improving occupancy rates, disciplined capital allocation, and a solid balance sheet position American Healthcare REIT for sustained growth and attractive returns.
Best Momentum Stocks to Buy for September 27th
MHO, RACE and AHR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 27, 2024.
American Healthcare REIT (AHR) Moves to Strong Buy: Rationale Behind the Upgrade
American Healthcare REIT (AHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Momentum Stocks to Buy for September 23rd
AU, AHR and HWM made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 23, 2024.
New Strong Buy Stocks for September 23rd
OPRA, SBSI, AU, AHR and LYTS have been added to the Zacks Rank #1 (Strong Buy) List on September 23, 2024.
Fed Goes Big
U.S. equity and bond markets exhibited a surprisingly muted response to the Federal Reserve's decision to cut interest rates by 50 basis points, a distinctly dovish pivot following its aggressive tightening cycle. Longer-term benchmark rates actually climbed modestly after the decision in a "curve steepening" trade, reflecting concern that the Fed's dovish tack could revive some inflationary pressures. Led by "pro-cyclical" market segments, the S&P 500 posted gains of 1.1% this week, breaching fresh record highs on Thursday before paring post-Fed gains late in the week.
American Healthcare REIT, Inc. (AHR) Q2 2024 Earnings Call Transcript
American Healthcare REIT, Inc. (NYSE:AHR ) Q2 2024 Earnings Conference Call August 6, 2024 1:00 PM ET Company Participants Alan Peterson - Vice President of Investor Relations & Finance Danny Prosky - President & Chief Executive Officer Gabe Willhite - Chief Operating Officer Brian Peay - Chief Financial Officer Stefan Oh - Chief Investment Officer Conference Call Participants Joshua Dennerlein - Bank of America Austin Wurschmidt - KeyBanc Capital Markets Ronald Kamdem - Morgan Stanley Michael Carroll - RBC Capital Markets Michael Griffin - Citigroup John Pawlowski - Green Street Operator Hello and thank you for standing by. At this time, I would like to welcome you to the American Healthcare REIT Q2 2024 Earnings Conference Call.
American Healthcare REIT Set To Grow With Demographic Tailwinds And Expansion
AHR focuses on nursing homes and health infrastructure, utilizing both triple-net leases and RIDEA properties for operational upside. Demographic tailwinds and cost improvements support long-term growth potential for AHR, with a 6.5% yield. AHR's estimated fair value is $19.50, with strong market conditions and potential for future growth in the healthcare sector.
